Aspen’s half-year revenue increases 13% to R19.8 billion

Johannesburg – JSE Limited listed Aspen Pharmacar… 继续阅读Aspen’s half-year revenue increases 13% to R19.8 billion

Stephen Saad receives the coveted CNBC Africa Entrepreneur of the Year Award

Stephen Saad’s acceptance speech for the Entrepre… 继续阅读Stephen Saad receives the coveted CNBC Africa Entrepreneur of the Year Award

Stephen Saad scoops Entrepreneur of the Year Award

Johannesburg. Stephen Saad, Aspen Group Chief Executive… 继续阅读Stephen Saad scoops Entrepreneur of the Year Award

Aspen’s comparable revenue increases by 12% to R35.4 billion

Aspen’s comparable revenue increases by 12% to R35.4 bi… 继续阅读Aspen’s comparable revenue increases by 12% to R35.4 billion

Aspen AstraZeneca Anaesthetics Portfolio Agreement

Aspen Holdings is pleased to announce that its wholly o… 继续阅读Aspen AstraZeneca Anaesthetics Portfolio Agreement

Aspen demonstrates economic growth and specialized technologies contributions to Deputy President Cyril Ramaphosa

Port Elizabeth. JSE-listed Aspen, the largest pharmaceu… 继续阅读Aspen demonstrates economic growth and specialized technologies contributions to Deputy President Cyril Ramaphosa

Aspen’s profit after tax increases by 35%

Aspen’s profit after tax increases by 35% Johannesburg … 继续阅读Aspen’s profit after tax increases by 35%

Aspen’s revenue increases 22% to R36 billion

Johannesburg – JSE Limited listed Aspen Pharmacare Hold… 继续阅读Aspen’s revenue increases 22% to R36 billion

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.